An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers
Part of paid clinical trials in Clovis, California.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT03662659
- Phase
- PHASE2
- Status
- Completed
Conditions
- Cancer of the Stomach
- Esophagogastric Junction
- Gastric Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- BMS-986213 — BIOLOGICALRelatlimab + Nivolumab specified dose on specified days
- Nivolumab — BIOLOGICALSpecified dose on specified days
- XELOX — DRUGOxaliplatin + capecitabine
- FOLFOX — DRUGOxaliplatin + leucovorin + fluorouracil
- SOX — DRUGOxaliplatin + tegafur/gimeracil/oteracil potassium
Study Details
The purpose of this study is to determine the efficacy and safety of investigational drug relatlimab plus nivolumab in combination with chemotherapy in participants with unresectable, untreated, locally advanced or metastatic gastric or GEJ cancer.
Key Dates
- Start date
- Oct 16, 2018
- Status verified
- Jan 2025
- Primary completion
- Aug 27, 2020
- Completion
- Jan 18, 2024
Study Design
- Enrollment
- 274 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: BMS-986213 + investigator's choice chemotherapyBMS-986213 + XELOX or BMS-986213 + FOLFOX or BMS-986213 + SOX
- Experimental: Nivolumab + investigator's choice chemotherapyNivolumab + XELOX or Nivolumab + FOLFOX or Nivolumab + SOX
Primary Outcome Measure
BICR-Assessed Objective Response Rate (ORR) in Randomized LAG-3 Positive (>=1 %) Participants [ Time Frame: Up to 25 months ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Local Institution - 0049 | Clovis | California | 93611 | - |
| Local Institution - 0064 | Duarte | California | 91010-3012 | - |
| Scripps Clinic | La Jolla | California | 92037 | - |
| Local Institution - 0040 | Los Angeles | California | 90033 | - |
| Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92663 | - |
| Local Institution - 0041 | Orange | California | 92868 | - |
| Local Institution - 0077 | Santa Monica | California | 90404 | - |
| Local Institution - 0056 | Aurora | Colorado | 80045 | - |
| Local Institution - 0062 | New Haven | Connecticut | 06520 | - |
| Local Institution - 0050 | Hackensack | New Jersey | 07601 | - |
| Local Institution - 0054 | Dallas | Texas | 75216 | - |
| Virginia Cancer Institute | Richmond | Virginia | 23230 | - |
| Local Institution - 0052 | Seattle | Washington | 98109 | - |
Find similar trials in Clovis, CA
By condition
By specialty
Related Studies
- The Gastric Cancer Foundation: A Gastric Cancer RegistryRecruiting · Stanford University · Stanford, California
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California
- Combination of TATE and PD-1 Inhibitor in Liver CancerPHASE2 · Recruiting · Teclison Ltd. · Orange, California